Fingerprint
Dive into the research topics of 'A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer
Christopher W. Ryan, Walter M. Stadler, Nicholas J. Vogelzang
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations